Second Thoughts on Out-of-Favor Parkinson’s Disease Treatment

October 7, 2014

(The Wall Street Journal) – Several patients with Parkinson’s disease who received brain-tissue transplants from fetuses in the early 1990s have needed little or no medicine to treat the disease ever since—an outcome virtually unheard of in the course of the disease, researchers have found. The results are particularly striking because the treatment is controversial and has been questioned by some researchers in the field. Bolstered by these promising cases, 14 European hospitals, research institutions and companies have launched a new, controversial trial on fetal-cell transplants, known as Transeuro.